Genenta Science SpA ADR (GNTA) — Cash Flow-to-Debt Ratio
Genenta Science SpA ADR (GNTA) has a Cash Flow-to-Debt Ratio of -0.17x as of March 2026, meaning its operating cash flow of $-1.69 Million could theoretically repay 0% of its total liabilities ($10.05 Million) in one year. See GNTA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genenta Science SpA ADR Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Genenta Science SpA ADR across 7 annual periods. Also explore GNTA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Genenta Science SpA ADR (2019–2025)
Year-by-year debt coverage analysis for Genenta Science SpA ADR. For market capitalisation and broader financial context, see GNTA stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.68x | $-6.87 Million | $10.05 Million | ▲ +74.5% |
| 2024 | -2.68x | $-6.24 Million | $2.33 Million | ▲ +54.2% |
| 2023 | -5.85x | $-11.21 Million | $1.91 Million | ▼ -81.4% |
| 2022 | -3.23x | $-7.42 Million | $2.30 Million | ▲ +46.0% |
| 2021 | -5.97x | $-6.96 Million | $1.17 Million | ▼ -132.2% |
| 2020 | -2.57x | $-6.04 Million | $2.35 Million | ▼ -157.9% |
| 2019 | -1.00x | $-2.49 Million | $2.50 Million | — |